CRC01 Clinical Trials

1 actively recruiting trial

No change since June 2026

Pipeline

Phase 1/2: 1

Top Sponsors

Curocell Inc.1

Indications

Refractory Large B-cell Lymphoma1
Relapsed Large B-cell Lymphoma1
Transformed Follicular Lymphoma (tFL)1
ALL (Acute B-Lymphoblastic Leukemia)1
Primary Mediastinal Large B-cell Lymphoma (PMBCL)1

Other1 trial

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.